Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond Denmark
Novo Holdings, the investment company that controls Novo Nordisk and holds the wealth of the Novo Nordisk Foundation, is backing a fund aimed at Italian drug startups, according to Bloomberg. The move extends a pattern that has seen the Danish investor push capital into life sciences hubs well…
No discussion yet. Be the first to share your thoughts!